JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A2576 E-64
6 Citation

Target: Cathepsins|Calpains|Papains

Summary: cysteine proteases inhibitor

≥49.1 mg/mL
A2602 Calpain Inhibitor I, ALLN
5 Citation

Target: Cathepsins|Calpains

Summary: Calpain I/II/ B/L inhibitor
A2577 Batimastat (BB-94)
17 Citation

Summary: MMP inhibitor

≥23.88 mg/mL
A4166 EPZ5676
2 Citation

Target: DOT1L

Summary: DOT1L inhibitor,potent and SAM competitive

≥28.15 mg/mL
A4152 BMS-911543

Target: JAK

Summary: JAK2 inhibitor,selective small molecule

≥43.3 mg/mL
A2614 Bortezomib (PS-341)
52 Citation

Target: Proteasome

Summary: proteasome inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
A1909 BIX 01294
2 Citation

Target: G9a

Summary: G9a and GLP inhibitor

≥24.45 mg/mL
A1910 Bromodomain Inhibitor, (+)-JQ1
66 Citation

Target: Bromodomains

Summary: BET bromodomain inhibitor

≥22.85 mg/mL
A4304 Rosiglitazone
4 Citation

Summary: Potent PPARγ agonist

insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
A4357 Dorzolamide HCl

Summary: Carbonic anhydrase inhibitor

insoluble in EtOH; ≥13 mg/mL